Calendar of gene regulation events online

 

The calendar below lists webinars and meetings relevant to gene regulation. All times below are in GMT (London, UK). The link to export these events to Outlook or Google Calendar is at the bottom of this page. The calendar below includes all virtual events related to gene regulation, not limited to those organised by Fragile Nucleosome. To add your own virtual event that is not yet in our list, please email [email protected] For a list of conferences and schools in the area of gene regulation, see the separate page “conferences, meetings and schools”. Also, have a look at complementary lists of webinars at  The Node (developmental biology and related subjects), Physics of Life (biophysics) and mathseminars.org (mathematics & physics).

 

Loading Events

« All Events

  • This event has passed.

Fox Chase Cancer Center Cancer Epigenetics Institute Virtual Symposium: From Nucleic Acids to 3D Genomes to Therapeutics

March 2

Free

Fox Chase Cancer Center Cancer Epigenetics Institute Virtual Symposium: From Nucleic Acids to 3D Genomes to Therapeutics

Date & Time
Tuesday, March 2, 2021
8:45am to 4:30pm

Location

Virtual – Zoom

Registration Information

Event Overview

Mechanisms that impact the way our genomes are expressed and stabilized without changing its DNA sequence are influenced through the epigenetic character of chromatin. DNA, RNA, and histone modifications as well as chromatin structure contribute to the epigenetic mechanisms controlling gene expression, genome stability, cell fate and differentiation. Both the scientific and clinical communities recognize that epigenetic dysregulation contributes to tumorigenesis, tumor drug response and resistance with changes to the tumor microenvironment, likely leading to the currently unexplained variability in cancer survivorship. Cancer genome sequencing efforts have highlighted mutations in numerous epigenetic factors altering chromatin features, which in turn, deregulates gene expression, genome stability, replication, and cell fate. The posttranscriptional modulation of RNA (or epitranscriptomics) has emerged as another layer of epigenetic control impacting tumorigenesis. Therefore, the enzymes regulating histone and nucleic modifications serve as novel targets and provide opportunities to develop biomarkers and novel therapies. This one-day symposium will feature world-leaders in cancer epigenetics that will highlight discoveries related to epigenetic mechanisms driving tumorigenesis and novel therapeutic opportunities to better target cancer.

Speakers

Margaret (“Peggy”) Goodell, PhD
Baylor College of Medicine

Mark Dawson, MBBS (Hons), BMedSci, FRACP, FRCPA, PhD (Cantb)
University of Melbourne

Cheryl Arrowsmith, PhD
University of Toronto & Princess Margaret Cancer Centre

Sharon Y.R. Dent, PhD
The University of Texas MD Anderson Cancer Center

Peter A. Jones, PhD, DSc (hon)
Van Andel Institute

Kristian Helin, PhD
Memorial Sloan Kettering Cancer Center

Tony Kouzarides, FMedSci, FRS
University of Cambridge

Ari M. Melnick, MD
Weill Cornell Medicine

Jane Skok, PhD
New York University Grossman School of Medicine

Cigall Kadoch, PhD
Dana-Farber Cancer Institute & Harvard Medical School